In this study, we set out to evaluate the costs and effectiveness of the 2 most used therapies in our region, ATD or RAI. 23 patients, 6 men and 16 women, with a mean age of 35.4 years, treated with ATD, and 35 patients, 5 men and 30 women, mean age of 39.4 years, treated with RAI, were studied. After 2 years receiving ATD, 21 patients achieved euthyroidism and 2 remained hyperthyroid. In the RAI group, 21 patients presented hypothyroidism […]

While the diagnosis of Graves’ disease in childhood and adolescence is relatively straightforward, its treatment remains controversial. The first choice therapy is the use of anti-thyroid drugs, although side effects are more frequent than in adults and remission is low. Surgery is not usually indicated as initial treatment. Instead, it is generally recommended after recidive of the disease or due to side effects of medical treatment. The use of radioiodine therapy is increasing in this age group, especially in North […]

Thionamides are drugs frequently used for the treatment of hyperthyroidism in Basedow-Graves’ disease (BGD), both as primary therapy and for the preparation of patients undergoing surgery or radioiodine therapy. Adverse reactions related to these drugs affect 3-12% of patients, varying from minor and transient reactions, more frequently, to uncommon, severe and potentially fatal ones. We describe a patient diagnosed with hyperthyroidism due to BGD, who developed polyarthralgia followed by ulcer-necrotizing cutaneous lesions in the distal extremities of the legs, after […]